Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
7.55
-0.30 (-3.82%)
Mar 31, 2025, 1:41 PM EDT - Market open

Zevra Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
23.6127.4610.1628.6513.29
Upgrade
Revenue Growth (YoY)
-14.02%170.26%-64.53%115.61%3.50%
Upgrade
Cost of Revenue
7.422.170.222.061.31
Upgrade
Gross Profit
16.225.299.9426.5911.98
Upgrade
Selling, General & Admin
54.9235.0915.619.238.44
Upgrade
Research & Development
42.0439.0319.239.648.32
Upgrade
Operating Expenses
103.274.8934.8418.8616.76
Upgrade
Operating Income
-87-49.6-24.97.73-4.78
Upgrade
Interest Expense
-7.35-1.5-0.34-0.38-7.09
Upgrade
Interest & Investment Income
2.184.541.510.260.09
Upgrade
Other Non Operating Income (Expenses)
2.06-0.115.16-0.03-0.18
Upgrade
EBT Excluding Unusual Items
-90.12-46.66-8.577.59-11.97
Upgrade
Merger & Restructuring Charges
-----0.83
Upgrade
Gain (Loss) on Sale of Investments
-0.020.61-0.58-0.01-
Upgrade
Other Unusual Items
----16.1-
Upgrade
Pretax Income
-90.14-46.05-26.81-8.52-12.79
Upgrade
Income Tax Expense
15.37--0.030.03-0.03
Upgrade
Net Income
-105.51-46.05-26.77-8.56-12.76
Upgrade
Preferred Dividends & Other Adjustments
---54.34-
Upgrade
Net Income to Common
-105.51-46.05-26.77-62.9-12.76
Upgrade
Shares Outstanding (Basic)
463534304
Upgrade
Shares Outstanding (Diluted)
463534304
Upgrade
Shares Change (YoY)
30.46%2.79%15.87%647.72%114.79%
Upgrade
EPS (Basic)
-2.28-1.30-0.78-2.11-3.21
Upgrade
EPS (Diluted)
-2.28-1.30-0.78-2.11-3.21
Upgrade
Free Cash Flow
-69.67-33.83-18.8110.34-1.97
Upgrade
Free Cash Flow Per Share
-1.51-0.95-0.550.35-0.49
Upgrade
Gross Margin
68.59%92.09%97.81%92.81%90.18%
Upgrade
Operating Margin
-368.47%-180.63%-245.07%26.98%-35.98%
Upgrade
Profit Margin
-446.85%-167.69%-263.48%-219.54%-96.03%
Upgrade
Free Cash Flow Margin
-295.04%-123.20%-185.12%36.08%-14.84%
Upgrade
EBITDA
-80.61-48.6-23.967.99-4.51
Upgrade
EBITDA Margin
--176.97%-235.78%27.87%-33.92%
Upgrade
D&A For EBITDA
6.391.010.940.260.27
Upgrade
EBIT
-87-49.6-24.97.73-4.78
Upgrade
EBIT Margin
--180.63%-245.07%26.98%-35.98%
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q